Bioequivalence of Two Formulations of Meropenem Intravenous Injection
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
A randomized, single-dose, two-way crossover study to evaluate bioequivalence of two
formulations of meropenem (meropenem intravenous injection 0.5 g) after intravenous infusion
in healthy volunteers.